We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-8.32%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.29B
AUM Growth
-$303M
Cap. Flow
+$76.4M
Cap. Flow %
2.32%
Top 10 Hldgs %
14.37%
Holding
1,576
New
105
Increased
568
Reduced
547
Closed
231

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.9M
2
KMX icon
CarMax
KMX
+$10.9M
3
NFLX icon
Netflix
NFLX
+$7.39M
4
UAL icon
United Airlines
UAL
+$6.3M
5
AMZN icon
Amazon
AMZN
+$5.34M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$6.94M
2
QCOM icon
Qualcomm
QCOM
+$6.76M
3
BHC icon
Bausch Health
BHC
+$5.37M
4
KMI icon
Kinder Morgan
KMI
+$5.15M
5
PLL
PALL CORP
PLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Healthcare 15.4%
2 Financials 10.61%
3 Consumer Discretionary 9.72%
4 Industrials 9.63%
5 Technology 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FINL
26
DELISTED
Finish Line
FINL
$19.6M 0.59%
1,014,483
+139,833
+16% +$3.7M
DIS icon
27
Walt Disney
DIS
$167B
$19.2M 0.58%
187,493
+35,838
+24% +$3.9M
ORLY icon
28
O'Reilly Automotive
ORLY
$72.7B
$19M 0.58%
1,138,410
+265,350
+30% +$4.28M
APU
29
DELISTED
AmeriGas Partners, L.P.
APU
$18.5M 0.56%
445,167
+61,567
+16% +$2.75M
QQQ icon
30
Invesco QQQ Trust
QQQ
$452B
$18.3M 0.56%
180,289
-1,166
-0.6% -$125K
AMGN icon
31
Amgen
AMGN
$207B
$17.9M 0.54%
129,261
+1,108
+0.9% +$175K
MRK icon
32
Merck
MRK
$323B
$17.6M 0.53%
372,543
+21,800
+6% +$1.16M
PEP icon
33
PepsiCo
PEP
$191B
$17.2M 0.52%
181,885
+19,854
+12% +$1.89M
WLY icon
34
John Wiley & Sons Class A
WLY
$2.65B
$17.1M 0.52%
342,070
+3,000
+0.9% +$156K
MO icon
35
Altria Group
MO
$116B
$17M 0.52%
312,024
-3,508
-1% -$188K
BIIB icon
36
Biogen
BIIB
$30.3B
$16.8M 0.51%
57,503
+3,895
+7% +$1.29M
BMY icon
37
Bristol-Myers Squibb
BMY
$133B
$16.4M 0.5%
277,106
-19,144
-6% -$1.21M
PG icon
38
Procter & Gamble
PG
$335B
$16.4M 0.5%
227,731
-1,570
-0.7% -$118K
C icon
39
Citigroup
C
$223B
$15.2M 0.46%
305,850
-7,666
-2% -$419K
CVX icon
40
Chevron
CVX
$389B
$15M 0.45%
189,581
-4,379
-2% -$369K
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$14.9M 0.45%
77,692
-2,154
-3% -$437K
UAL icon
42
United Airlines
UAL
$39.6B
$14.5M 0.44%
272,870
+111,756
+69% +$6.3M
MIC
43
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$14.1M 0.43%
188,452
+3,212
+2% +$256K
EHC icon
44
Encompass Health
EHC
$11B
$14M 0.43%
459,423
+84,931
+23% +$2.96M
EOG icon
45
EOG Resources
EOG
$78.1B
$13.4M 0.41%
184,691
+51,431
+39% +$4M
DD
46
DELISTED
Du Pont De Nemours E I
DD
$13.4M 0.41%
278,602
-2,146
-0.8% -$115K
MET icon
47
MetLife
MET
$62.3B
$13.4M 0.41%
317,787
-6,838
-2% -$319K
MDT icon
48
Medtronic
MDT
$109B
$13.3M 0.41%
199,393
+5,691
+3% +$419K
DD icon
49
DuPont de Nemours
DD
$18.6B
$13.3M 0.4%
123,856
-9,222
-7% -$1.07M
DXJ icon
50
WisdomTree Japan Hedged Equity Fund
DXJ
$7.07B
$13M 0.39%
266,407
+7,885
+3% +$426K

Similar funds

Oppenheimer & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Oppenheimer & Co held 1,576 positions worth $3.29B, down 8.4% from $3.59B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2015 filing shows 105 new, 568 increased, 547 reduced and 231 closed positions. Its largest new stake was PayPal: 112,571 shares worth $3.49M. The largest sale was ConocoPhillips, an estimated $6.94M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Oppenheimer & Co's largest Q3 2015 buy was PayPal: 112,571 shares worth $3.49M.
  • Oppenheimer & Co added most to Gilead Sciences in Q3 2015, an estimated $15.9M increase.
  • Oppenheimer & Co's biggest Q3 2015 reduction was ConocoPhillips, cutting an estimated $6.94M.
  • Oppenheimer & Co fully exited PALL CORP in Q3 2015, selling an estimated $5.04M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.29B portfolio in Q3 2015.
  • Oppenheimer & Co opened 105 new positions and closed 231 in Q3 2015.
  • Oppenheimer & Co's portfolio value fell 8.4% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q3 2015, filed 13 Nov 2015.